Finansų valdymas 
Tarptautinis verslas 3 kurso 1  grupė
Atvejų analizė sąrašas Prezentacijos pateikimo savalaikiškumas, skaidrių kokybė, oratorinis menas, auditorijos įtraukimas į atvejo analizę 0-3 Analizuojamos problemos sudėtingumas 0-3 Atvejo analizės platumas, t.y. pakankamai daug atlikta darbo 0-4 Atvejo analizės gilumas, t.y. panaudoti sudėtingi analizės metodai 0-4 Surinkta papildoma, įdomi ir vertinga medžiaga  0-2 Apibendrinimas, išvados, kas įsimintina, kuo vertingas pateiktas atvejis, kur galima pritaikyti įgytas žinias 0-2 Testo klausimų kokybė 0-2 Oponavimas arba aktyvus dalyvavimas analizuojant atvejus 0-1 
                                                                                                                                                                                                                                   
Eil Nr. Pusl. Pavadinimas Dalyviai / Oponentai  Pristatymo data Pristatymo eilė Pristatymo skaidrės Papildoma medžiaga 1 Papildoma medžiaga 2 Vertinimas
1 365-369 Valuing Capital investment Projects             0                
  365-370 Valuing Capital investment Projects             0                
2 365-369 Valuing Capital investment Projects             0                
3 371-376 Merck & Company: Evaluating a Drug Licensing Opportunity             0                
4 371-376 Merck & Company: Evaluating a Drug Licensing Opportunity             0                
  371-376 Merck & Company: Evaluating a Drug Licensing Opportunity             0                
5 377-379 Tree Values             0                
6 377-379 Tree Values             0                
  377-379 Tree Values             0                
7 381-394 The Super Project              0                
8 381-394 The Super project             0                
  381-394 The Super project             0                
9 395-403 Net Flix Deivydas Latvis           0                
10 395-403 Net Flix Gabija Masiulytė           0                
  395-403 Net Flix Meda Dzikaitė           0                
  395-403 Net Flix             0                
  395-403 Net Flix             0                
11 405-418 A-Rod: Signing the Best Player in Baseball  Džiuginta Dunkauskaitė           11 3 2 2 1 1 1   1
  405-418 A-Rod: Signing the Best Player in Baseball  Paulina Zinkevičiūte           10 3 2 2 1 1 1    
  405-418 A-Rod: Signing the Best Player in Baseball  Luku Mileriu           10 3 2 2 1 1 1    
12 405-418 A-Rod: Signing the Best Player in Baseball             9 3 2 2   1 1    
  405-418 A-Rod: Signing the Best Player in Baseball             9 3 2 2   1 1    
13 419-423 Ocean Carriers             9 3 2 2   1 1    
14 419-423 Ocean Carriers             9 3 2 2   1 1    
  419-423 Ocean Carriers             9 3 2 2   1 1    
15 405-418 Whirlpool Europe             9 3 2 2   1 1    
16 405-418 Whirlpool Europe             9 3 2 2   1 1    
  405-418 Whirlpool Europe             9 3 2 2   1 1    
  405-418 Whirlpool Europe             9 3 2 2   1 1    
17 431-434 Health Development Corporation              9 3 2 2   1 1    
18 431-435 Health Development Corporation              9 3 2 2   1 1    
19 431-436 Health Development Corporation              9 3 2 2   1 1    
20 431-437 Health Development Corporation              9 3 2 2   1 1    
21 431-438 Health Development Corporation              9 3 2 2   1 1    
22 431-439 Health Development Corporation              9 3 2 2   1 1    
23 431-440 Health Development Corporation              9 3 2 2   1 1    
24 431-441 Health Development Corporation              9 3 2 2   1 1    
25 431-442 Health Development Corporation              0                
  431-443 Health Development Corporation              0                
  257 The Investment Detective   (Investment criteria and discounted cash flow)             0                
  257 The Investment Detective   (Investment criteria and discounted cash flow)             0                
  257 The Investment Detective   (Investment criteria and discounted cash flow)             0                
  259 Worldwide Paper Company  (Analysis of an expansion investment)              0                
  259 Worldwide Paper Company  (Analysis of an expansion investment)              0                
  259 Worldwide Paper Company  (Analysis of an expansion investment)              0                
  263 Target Corporation  (Multifaceted capital investment decisions)    Viktorija Grablevska           9 3 2 2   1 1    
  263 Target Corporation  (Multifaceted capital investment decisions)    Rasa Gruodytė           10 3 2 2   1 1   1
  263 Target Corporation  (Multifaceted capital investment decisions)    Liliana Baranauskaitė.            10 3 2 2   1 1   1
  283 Aurora Textile Company  (Analysis of an automation investment)   Gabrielius Pranulis           9 3 2 2   1 1    
  283 Aurora Textile Company  (Analysis of an automation investment)   Mantas Trublinas            9 3 2 2   1 1    
  283 Aurora Textile Company  (Analysis of an automation investment)               0                
  295 Compass Records  (Analysis of working capital investment)                0                
  295 Compass Records  (Analysis of working capital investment)                0                
  295 Compass Records  (Analysis of working capital investment)                0                
  309 Victoria Chemicals plc (A): The Merseyside Project  (Relevant cash flows)               0                
  309 Victoria Chemicals plc (A): The Merseyside Project  (Relevant cash flows)             0                
  309 Victoria Chemicals plc (A): The Merseyside Project  (Relevant cash flows)               0                
  317 Victoria Chemicals plc (B): Merseyside and Rotterdam Projects  (Mutually exclusive investment opportunities)  Ramūnas Pranckevičius           8 3 2 2     1    
  317 Victoria Chemicals plc (B): Merseyside and Rotterdam Projects  (Mutually exclusive investment opportunities)  Karolis Šukaitis           9 3 2 2     1   1
  317 Victoria Chemicals plc (B): Merseyside and Rotterdam Projects  (Mutually exclusive investment opportunities)  Linas Peleckas           9 3 2 2     1   1
  325 Euroland Foods S.A.  (Strategic resource allocation)               0                
  325 Euroland Foods S.A.  (Strategic resource allocation)               0                
  325 Euroland Foods S.A.  (Strategic resource allocation)               0                
  337 Star River Electronics Ltd.(Capital project analysis and forecasting)              0                
  337 Star River Electronics Ltd.(Capital project analysis and forecasting)              0                
  337 Star River Electronics Ltd.(Capital project analysis and forecasting)              0                
1 277-296  Introduction to Derivative Instruments  Andrius Lesevičius           9 3 2   2 1 1    
2 277-296  Introduction to Derivative Instruments              9 3 2   2 1 1